Inactive Instrument

Cornerstone Therapeutics, Inc. Stock

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/02/14	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
03/02/14	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
01/02/14	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/11/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
01/11/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)
16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	01/01/2021
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.53%	+2.54%	+22.14%	+74.08%	50.03B
OTSUKA HOLDINGS CO., LTD.	-1.81%	-0.49%	+48.83%	+107.71%	36.6B
CIPLA LIMITED	+0.46%	+4.44%	-1.97%	+25.02%	12.47B
ZYDUS LIFESCIENCES LIMITED	+1.05%	+1.63%	+18.73%	+77.76%	11.77B
KRKA, D. D.	-1.33%	-0.76%	+30.73%	+127.63%	9.04B
ONO PHARMACEUTICAL CO., LTD.	-2.99%	-2.09%	+45.28%	-11.87%	7.03B
GEDEON RICHTER	+0.51%	+1.46%	+13.46%	+32.06%	6.79B
GLENMARK PHARMACEUTICALS LIMITED	+1.99%	+1.91%	+8.03%	+183.42%	6.6B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.39%	+3.39%	-35.25%	+4.49%	5.49B
Average	-0.25%	+0.97%	+16.66%	+68.92%	16.2B
Weighted average by Cap.	-0.61%	+1.27%	+24.94%	+78.17%

Employees

Sector